SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. Jon Stoessl, Central pharmacokinetics of levodopa: Lessons from imaging studies, Movement Disorders, 2015, 30, 1
  2. 2
    Fang Ba, W.R. Wayne Martin, Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice, Parkinsonism & Related Disorders, 2015, 21, 2, 87

    CrossRef

  3. 3
    Shinsuke Fujioka, Bradley F. Boeve, Joseph E. Parisi, Pawel Tacik, Naoya Aoki, Audrey J. Strongosky, Matt Baker, Monica Sanchez-Contreras, Owen A. Ross, Rosa Rademakers, Vesna Sossi, Dennis W. Dickson, A. Jon Stoessl, Zbigniew K. Wszolek, A familial form of parkinsonism, dementia, and motor neuron disease: A longitudinal study, Parkinsonism & Related Disorders, 2014, 20, 11, 1129

    CrossRef

  4. 4
    Begoña Villar-Cheda, Antonio Dominguez-Meijide, Rita Valenzuela, Noelia Granado, Rosario Moratalla, Jose L. Labandeira-Garcia, Aging-related dysregulation of dopamine and angiotensin receptor interaction, Neurobiology of Aging, 2014, 35, 7, 1726

    CrossRef

  5. 5
    A. Jon Stoessl, Developments in neuroimaging: positron emission tomography, Parkinsonism & Related Disorders, 2014, 20, S180

    CrossRef

  6. 6
    Francesco Brigo, Roberto Erro, Antonio Marangi, Kailash Bhatia, Michele Tinazzi, Differentiating drug-induced parkinsonism from Parkinson's disease: An update on non-motor symptoms and investigations, Parkinsonism & Related Disorders, 2014, 20, 8, 808

    CrossRef

  7. 7
    J. Arbizu, M.R. Luquin, J. Abella, R. de la Fuente-Fernández, R. Fernandez-Torrón, D. García-Solís, P. Garrastachu, J.M. Jiménez-Hoyuela, M. Llaneza, F. Lomeña, C. Lorenzo-Bosquet, M.J. Martí, J.C. Martinez-Castrillo, P. Mir, M. Mitjavila, J. Ruiz-Martínez, L. Vela, Functional neuroimaging in the diagnosis of patients with parkinsonism: Update and recommendations for clinical use, Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2014, 33, 4, 215

    CrossRef

  8. 8
    LinLin Tian, Morvarid Karimi, Chris A. Brown, Susan K. Loftin, Joel S. Perlmutter, In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment, Brain Research, 2014, 1571, 49

    CrossRef

  9. 9
    J. Arbizu, M.R. Luquin, J. Abella, R. de la Fuente-Fernández, R. Fernandez-Torrón, D. García-Solís, P. Garrastachu, J.M. Jiménez-Hoyuela, M. Llaneza, F. Lomeña, C. Lorenzo-Bosquet, M.J. Martí, J.C. Martinez-Castrillo, P. Mir, M. Mitjavila, J. Ruiz-Martínez, L. Vela, Neuroimagen funcional en el diagnóstico de pacientes con síndrome parkinsoniano: actualización y recomendaciones para el uso clínico, Revista Española de Medicina Nuclear e Imagen Molecular, 2014, 33, 4, 215

    CrossRef

  10. 10
    Marios Politis, Neuroimaging in Parkinson disease: from research setting to clinical practice, Nature Reviews Neurology, 2014, 10, 12, 708

    CrossRef

  11. 11
    Ali Shalash, Athanasia Alexoudi, Karina Knudsen, Jens Volkmann, Maximilian Mehdorn, Günther Deuschl, The impact of age and disease duration on the long term outcome of neurostimulation of the subthalamic nucleus, Parkinsonism & Related Disorders, 2014, 20, 1, 47

    CrossRef

  12. 12
    Konrad Szewczyk-Krolikowski, Paul Tomlinson, Kannan Nithi, Richard Wade-Martins, Kevin Talbot, Yoav Ben-Shlomo, Michele T.M. Hu, The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort, Parkinsonism & Related Disorders, 2014, 20, 1, 99

    CrossRef

  13. 13
    R. Cilia, A. Akpalu, F. S. Sarfo, M. Cham, M. Amboni, E. Cereda, M. Fabbri, P. Adjei, J. Akassi, A. Bonetti, G. Pezzoli, The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa, Brain, 2014, 137, 10, 2731

    CrossRef

  14. 14
    Glenda M. Halliday, James B. Leverenz, Jay S. Schneider, Charles H. Adler, The neurobiological basis of cognitive impairment in Parkinson's disease, Movement Disorders, 2014, 29, 5
  15. 15
    Chong S. Lee, Su-Jeong Kim, Seung Jun Oh, Hye Ok Kim, Sung-Cheol Yun, Doris Doudet, Jae Seung Kim, Uneven age effects of [18F]FP-CIT binding in the striatum of Parkinson’s disease, Annals of Nuclear Medicine, 2014, 28, 9, 874

    CrossRef

  16. 16
    Andre C. Felicio, A. Jon Stoessl, Imaging of the Human Brain in Health and Disease, 2014,

    CrossRef

  17. 17
    Raúl de la Fuente-Fernández, A predictive model of neurodegeneration in idiopathic REM-sleep behavior disorder, Parkinsonism & Related Disorders, 2013, 19, 11, 1009

    CrossRef

  18. 18
    Robert E. Burke, Karen O'Malley, Axon degeneration in Parkinson's disease, Experimental Neurology, 2013, 246, 72

    CrossRef

  19. 19
    Pankaj A. Agarwal, A. Jon Stoessl, Biomarkers for trials of neuroprotection in Parkinson's disease, Movement Disorders, 2013, 28, 1
  20. 20
    Philipp Mahlknecht, Werner Poewe, Defining premotor Parkinson’s disease: a window of opportunity for neuroprotection?, Neurodegenerative Disease Management, 2013, 3, 1, 61

    CrossRef

  21. 21
    Shichun Peng, Doris J. Doudet, Vijay Dhawan, Yilong Ma, Dopamine, PET Clinics, 2013, 8, 4, 469

    CrossRef

  22. 22
    Sagar Kansara, Akash Trivedi, Sheng Chen, Joseph Jankovic, Weidong Le, Early diagnosis and therapy of Parkinson’s disease: can disease progression be curbed?, Journal of Neural Transmission, 2013, 120, 1, 197

    CrossRef

  23. 23
    Mechelle M. Lewis, Guangwei Du, Michal Kidacki, Nisargkumar Patel, Michele L. Shaffer, Richard B. Mailman, Xuemei Huang, Higher iron in the red nucleus marks Parkinson's dyskinesia, Neurobiology of Aging, 2013, 34, 5, 1497

    CrossRef

  24. 24
    Philipp Mahlknecht, Werner Poewe, Is there a need to redefine Parkinson’s disease?, Journal of Neural Transmission, 2013, 120, S1, 9

    CrossRef

  25. 25
    Wolfgang H. Jost, Late or early treatment in Parkinson's disease?, Basal Ganglia, 2013, 3, 1, 1

    CrossRef

  26. 26
    Yoshikuni Mizuno, An update on the management of juvenile and young-onset Parkinson’s disease, Future Neurology, 2012, 7, 5, 581

    CrossRef

  27. 27
    Kathy Steece-Collier, David J. Rademacher, Katherine E. Soderstrom, Anatomy of graft-induced dyskinesias: Circuit remodeling in the parkinsonian striatum, Basal Ganglia, 2012, 2, 1, 15

    CrossRef

  28. 28
    I. Mitch Taylor, Andrea Jaquins-Gerstl, Susan R. Sesack, Adrian C. Michael, Domain-dependent effects of DAT inhibition in the rat dorsal striatum, Journal of Neurochemistry, 2012, 122, 2
  29. 29
    José Luis López-Sendón, María Angeles Mena, Justo García de Yébenes, Drug-Induced Parkinsonism in the Elderly, Drugs & Aging, 2012, 29, 2, 105

    CrossRef

  30. 30
    Glenda Halliday, Heather McCann, Claire Shepherd, Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?, Expert Review of Neurotherapeutics, 2012, 12, 6, 673

    CrossRef

  31. 31
    R. B. Postuma, A. E. Lang, J. F. Gagnon, A. Pelletier, J. Y. Montplaisir, How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder, Brain, 2012, 135, 6, 1860

    CrossRef

  32. 32
    G. Fénelon, J. -P. Brandel, La maladie de Parkinson de début tardif : différences et similitudes par rapport à celle des sujets plus jeunes ?, Les cahiers de l'année gérontologique, 2012, 4, 2, 36

    CrossRef

  33. 33
    A. Jon Stoessl, Neuroimaging in Parkinson's disease: from pathology to diagnosis, Parkinsonism & Related Disorders, 2012, 18, S55

    CrossRef

  34. 34
    Jana Godau, Anna Hussl, Praween Lolekha, A. Jon Stoessl, Klaus Seppi, Neuroimaging: Current role in detecting pre-motor Parkinson's disease, Movement Disorders, 2012, 27, 5
  35. 35
    Kurt A. Jellinger, Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts, Movement Disorders, 2012, 27, 1
  36. 36
    Andrew Siderowf, Anthony E. Lang, Premotor Parkinson's disease: Concepts and definitions, Movement Disorders, 2012, 27, 5
  37. 37
    J. Blesa, C. Pifl, M.A. Sánchez-González, C. Juri, M.A. García-Cabezas, R. Adánez, E. Iglesias, M. Collantes, I. Peñuelas, J.J. Sánchez-Hernández, M.C. Rodríguez-Oroz, C. Avendaño, O. Hornykiewicz, C. Cavada, J.A. Obeso, The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: A PET, histological and biochemical study, Neurobiology of Disease, 2012, 48, 1, 79

    CrossRef

  38. 38
    W.G. Meissner, When does Parkinson's disease begin? From prodromal disease to motor signs, Revue Neurologique, 2012, 168, 11, 809

    CrossRef

  39. 39
    A Jon Stoessl, WR Wayne Martin, Martin J McKeown, Vesna Sossi, Advances in imaging in Parkinson's disease, The Lancet Neurology, 2011, 10, 11, 987

    CrossRef

  40. 40
    R. Nandhagopal, L. Kuramoto, M. Schulzer, E. Mak, J. Cragg, J. McKenzie, S. McCormick, T. J. Ruth, V. Sossi, R. de la Fuente-Fernandez, A. J. Stoessl, Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease, Brain, 2011, 134, 11, 3290

    CrossRef

  41. 41
    Jan Marik, Sandra M. Sanabria Bohorquez, Simon-Peter Williams, Nicholas van Bruggen, New imaging paradigms in drug development: the PET imaging approach, Drug Discovery Today: Technologies, 2011, 8, 2-4, e63

    CrossRef

  42. 42
    Alex Iranzo, Francesc Valldeoriola, Francisco Lomeña, José Luis Molinuevo, Mónica Serradell, Manel Salamero, Albert Cot, Domènec Ros, Javier Pavía, Joan Santamaria, Eduardo Tolosa, Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study, The Lancet Neurology, 2011, 10, 9, 797

    CrossRef